#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Ovarian cancer Colorectal cancer Hepatocellular carcinoma Dermatitis atopic Dementia Alzheimer's type Asthma Breast cancer metastatic Type 2 diabetes mellitus Non-small cell lung cancer metastatic More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Cognitive disorder Vaginal cancer Synovial sarcoma metastatic Pseudomyxoma peritonei Alveolar rhabdomyosarcoma Lymphangioma Infection in an immunocompromised host Haemophagocytic lymphohistiocytosis Pericarditis Pyogenic sterile arthritis pyoderma gangrenosum and acne syndrome Spina bifida Osteogenesis imperfecta Burkitt's lymphoma Malignant central nervous system neoplasm Porphyria non-acute More trials…

    Learn about Rare Diseases

    Breast angiosarcoma – Treatment Acute respiratory distress syndrome – Life with Disease Richter’s syndrome – Trials in Disease Hereditary hypophosphataemic rickets – Trials in Disease Antisynthetase syndrome – Basic Information Focal segmental glomerulosclerosis Osteosarcoma recurrent – Treatment Mast cell activation syndrome – Diagnostics Carcinoid syndrome Gastrointestinal stromal tumour – Basic Information More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Emavusertib Bi 706321 Ribonucleic Acid K30 Soticlestat Brexpiprazole Fumarate Diltiazem Hydrochloride Ladarixin Maralixibat Chloride Ro7247669 F770/05 H2-Receptor Antagonists Inupadenant Hydrochloride Losmapimod Nizatidine Oxitriptan Treprostinil Lithium Azd3427 SALICYLIC ACID Abc-23A-116 More therapies…

    Learn about Your Condition

    Postoperative delirium Carcinoid tumour pulmonary Neurogenic bladder Juvenile psoriatic arthritis Abdominal pain Pulmonary fibrosis Monkeypox Skin ulcer Pyoderma Mitral valve incompetence Multiple system atrophy Polyneuropathy IgA nephropathy Foot deformity Neoplasm malignant More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Evangelismos S.A.

Evangelismos S.A.

Ipsiladou 45-47, Athens, 106 76, Greece

Want to learn more about this study or check if you can participate? Contact us.

  • Study of MK-1045 versus blinatumomab with tocilizumab in patients with relapsed or refractory B-cell acute lymphoblastic leukemia

    Recruiting

    4 1 1 1
    Investigated Diseases:
    • B-cell type acute leukaemia
    Investigated Drugs:
    • Blinatumomab
    • Tocilizumab
    Denmark France Greece Italy The Netherlands Spain +1

  • Study of MK-1045 plus rituximab in patients with newly diagnosed follicular lymphoma

    Recruiting

    4 1 1 1
    Investigated Diseases:
    • Follicular lymphoma
    Investigated Drugs:
    • Vinorelbine
    • Bendamustine Hydrochloride
    • Betamethasone Sodium Phosphate
    France Germany Greece Italy Poland Spain

  • Metronidazole, Bismuth Oxide and Tetracycline Hydrochloride Fixed‑Dose Combination vs Standard First‑line Therapy for Adults with Helicobacter pylori Infection

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Esomeprazole
    • Tetracycline Hydrochloride
    • Clarithromycin
    Greece

  • JNJ-79635322 versus Teclistamab in Patients with Relapsed or Refractory Multiple Myeloma After at Least 3 Prior Treatments

    Recruiting

    3 1 1
    Investigated Drugs:
    • IGG1 TRISPECIFIC MONOCLONAL ANTIBODY AGAINST T-CELL RECEPTOR CD3, B-CELL MATURATION ANTIGEN AND G PROTEIN-COUPLED RECEPTOR CLASS C GROUP 5 MEMBER D
    • Teclistamab
    France Germany Greece Italy The Netherlands Norway +1

  • Study of belantamab mafodotin with drug combination in adults aged 18 years and older with relapsed or refractory multiple myeloma

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Plasma cell myeloma refractory
    Investigated Drugs:
    • Belantamab Mafodotin
    • Bortezomib
    • Carfilzomib
    France Germany Greece The Netherlands Spain

  • A study to evaluate the effects of zenagamtide on weight and pain in patients with overweight or obesity and knee osteoarthritis

    Recruiting

    3 1
    Investigated Diseases:
    • Osteoarthritis
    • Obesity
    • Overweight
    Bulgaria Denmark Greece Italy Poland Spain

  • Study of Blinatumomab and a drug combination for older adults with newly diagnosed Philadelphia-negative B-cell precursor Acute Lymphoblastic Leukemia

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Acute lymphocytic leukaemia
    Investigated Drugs:
    • Idarubicin
    • Crisantaspase
    • Asparaginase
    Austria Belgium Bulgaria Czechia Denmark Estonia +11

  • Study of Sotorasib, Panitumumab and a drug combination for patients with metastatic colorectal cancer with KRAS p.G12C mutation.

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Colorectal cancer metastatic
    Investigated Drugs:
    • Sotorasib
    • Panitumumab
    • Irinotecan Hydrochloride Trihydrate
    Austria Belgium Bulgaria Czechia Denmark Estonia +12

  • A study of pembrolizumab, cetuximab, and MK-1084 for patients with advanced or metastatic non-small cell lung cancer with KRAS G12C mutations

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • K-ras gene mutation
    • Non-small cell lung cancer
    Investigated Drugs:
    • Carboplatin
    • Cetuximab
    • Mk-1084
    Finland Greece Italy The Netherlands Poland Spain

  • Efficacy and Safety of Subcutaneous Belimumab in Adults with Connective Tissue Disease-Associated Interstitial Lung Disease

    Recruiting

    3 1 1
    Investigated Diseases:
    • Interstitial lung disease
    Investigated Drugs:
    • Belimumab
    Belgium France Germany Greece Italy The Netherlands +1
Previous Page
1 2 3 4 … 14
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!